A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

PHASE4CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 10, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

November 20, 2021

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

Two doses of quadrivalent influenza vaccine

15ug hemagglutinin (HA) of each of the four influenza strains in 0.5 mL of sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate per injection.The routine of administation is Intramuscular injection into deltoid region.And the immunization schedule is two doses of quadrivalent influenza vaccine on day 0, 28.

BIOLOGICAL

One dose of quadrivalent influenza vaccine

15ug hemagglutinin (HA) of each of the four influenza strains in 0.5 mL of sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate per injection.The routine of administation is Intramuscular injection into deltoid region.And the immunization schedule is one dose of quadrivalent influenza vaccine on day 0.

Trial Locations (1)

223300

Huaiyin Center for Disease Control and Prevention, Huai'an

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT04997239 - A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old | Biotech Hunter | Biotech Hunter